Who’s Hired? Stada Names New Specialty Head

As Hyloris And Slayback Also Reveal New Appointments

Stada has appointed a new specialty head who will have global responsibility for the firm’s biosimilars business. Meanwhile, Hyloris has named a new business development chief and a generics industry veteran has joined Slayback’s board.

Boardroom Meeting Silhouette
Stada, Hyloris and Slayback have all made key executive appointments • Source: Shutterstock

More from Leadership

More from Generics Bulletin